img

Global Oligonucleotide Therapeutics Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oligonucleotide Therapeutics Drug Market Research Report 2024

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
According to Mr Accuracy reports’s new survey, global Oligonucleotide Therapeutics Drug market is projected to reach US$ 499.3 million in 2029, increasing from US$ 325 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oligonucleotide Therapeutics Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oligonucleotide Therapeutics Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics
Segment by Type
Antisense Oligonucleotide
Aptamer
Other

Segment by Application


Neuromuscular Diseases
ATTR
Hepatic VOD
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Oligonucleotide Therapeutics Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antisense Oligonucleotide
1.2.3 Aptamer
1.2.4 Other
1.3 Market by Application
1.3.1 Global Oligonucleotide Therapeutics Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neuromuscular Diseases
1.3.3 ATTR
1.3.4 Hepatic VOD
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Therapeutics Drug Market Perspective (2018-2029)
2.2 Oligonucleotide Therapeutics Drug Growth Trends by Region
2.2.1 Global Oligonucleotide Therapeutics Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oligonucleotide Therapeutics Drug Historic Market Size by Region (2018-2024)
2.2.3 Oligonucleotide Therapeutics Drug Forecasted Market Size by Region (2024-2029)
2.3 Oligonucleotide Therapeutics Drug Market Dynamics
2.3.1 Oligonucleotide Therapeutics Drug Industry Trends
2.3.2 Oligonucleotide Therapeutics Drug Market Drivers
2.3.3 Oligonucleotide Therapeutics Drug Market Challenges
2.3.4 Oligonucleotide Therapeutics Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Therapeutics Drug Players by Revenue
3.1.1 Global Top Oligonucleotide Therapeutics Drug Players by Revenue (2018-2024)
3.1.2 Global Oligonucleotide Therapeutics Drug Revenue Market Share by Players (2018-2024)
3.2 Global Oligonucleotide Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oligonucleotide Therapeutics Drug Revenue
3.4 Global Oligonucleotide Therapeutics Drug Market Concentration Ratio
3.4.1 Global Oligonucleotide Therapeutics Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Therapeutics Drug Revenue in 2022
3.5 Oligonucleotide Therapeutics Drug Key Players Head office and Area Served
3.6 Key Players Oligonucleotide Therapeutics Drug Product Solution and Service
3.7 Date of Enter into Oligonucleotide Therapeutics Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Therapeutics Drug Breakdown Data by Type
4.1 Global Oligonucleotide Therapeutics Drug Historic Market Size by Type (2018-2024)
4.2 Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Type (2024-2029)
5 Oligonucleotide Therapeutics Drug Breakdown Data by Application
5.1 Global Oligonucleotide Therapeutics Drug Historic Market Size by Application (2018-2024)
5.2 Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oligonucleotide Therapeutics Drug Market Size (2018-2029)
6.2 North America Oligonucleotide Therapeutics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024)
6.4 North America Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide Therapeutics Drug Market Size (2018-2029)
7.2 Europe Oligonucleotide Therapeutics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024)
7.4 Europe Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Therapeutics Drug Market Size (2018-2029)
8.2 Asia-Pacific Oligonucleotide Therapeutics Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oligonucleotide Therapeutics Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Oligonucleotide Therapeutics Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligonucleotide Therapeutics Drug Market Size (2018-2029)
9.2 Latin America Oligonucleotide Therapeutics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024)
9.4 Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size (2018-2029)
10.2 Middle East & Africa Oligonucleotide Therapeutics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Oligonucleotide Therapeutics Drug Introduction
11.1.4 Biogen Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.1.5 Biogen Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Detail
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Introduction
11.2.4 Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Detail
11.3.2 Jazz Pharmaceuticals Business Overview
11.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Introduction
11.3.4 Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.3.5 Jazz Pharmaceuticals Recent Development
11.4 Bausch & Lomb
11.4.1 Bausch & Lomb Company Detail
11.4.2 Bausch & Lomb Business Overview
11.4.3 Bausch & Lomb Oligonucleotide Therapeutics Drug Introduction
11.4.4 Bausch & Lomb Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.4.5 Bausch & Lomb Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Dynavax Technologies
11.6.1 Dynavax Technologies Company Detail
11.6.2 Dynavax Technologies Business Overview
11.6.3 Dynavax Technologies Oligonucleotide Therapeutics Drug Introduction
11.6.4 Dynavax Technologies Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.6.5 Dynavax Technologies Recent Development
11.7 Kastle therapeutics
11.7.1 Kastle therapeutics Company Detail
11.7.2 Kastle therapeutics Business Overview
11.7.3 Kastle therapeutics Oligonucleotide Therapeutics Drug Introduction
11.7.4 Kastle therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.7.5 Kastle therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oligonucleotide Therapeutics Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antisense Oligonucleotide
Table 3. Key Players of Aptamer
Table 4. Key Players of Other
Table 5. Global Oligonucleotide Therapeutics Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Oligonucleotide Therapeutics Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oligonucleotide Therapeutics Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Oligonucleotide Therapeutics Drug Market Share by Region (2018-2024)
Table 9. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Oligonucleotide Therapeutics Drug Market Share by Region (2024-2029)
Table 11. Oligonucleotide Therapeutics Drug Market Trends
Table 12. Oligonucleotide Therapeutics Drug Market Drivers
Table 13. Oligonucleotide Therapeutics Drug Market Challenges
Table 14. Oligonucleotide Therapeutics Drug Market Restraints
Table 15. Global Oligonucleotide Therapeutics Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Oligonucleotide Therapeutics Drug Market Share by Players (2018-2024)
Table 17. Global Top Oligonucleotide Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics Drug as of 2022)
Table 18. Ranking of Global Top Oligonucleotide Therapeutics Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Oligonucleotide Therapeutics Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oligonucleotide Therapeutics Drug Product Solution and Service
Table 22. Date of Enter into Oligonucleotide Therapeutics Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oligonucleotide Therapeutics Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Oligonucleotide Therapeutics Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Application (2018-2024)
Table 30. Global Oligonucleotide Therapeutics Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Oligonucleotide Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Oligonucleotide Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Oligonucleotide Therapeutics Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Oligonucleotide Therapeutics Drug Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Oligonucleotide Therapeutics Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Oligonucleotide Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Biogen Company Detail
Table 48. Biogen Business Overview
Table 49. Biogen Oligonucleotide Therapeutics Drug Product
Table 50. Biogen Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 51. Biogen Recent Development
Table 52. Sarepta Therapeutics Company Detail
Table 53. Sarepta Therapeutics Business Overview
Table 54. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product
Table 55. Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 56. Sarepta Therapeutics Recent Development
Table 57. Jazz Pharmaceuticals Company Detail
Table 58. Jazz Pharmaceuticals Business Overview
Table 59. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product
Table 60. Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 61. Jazz Pharmaceuticals Recent Development
Table 62. Bausch & Lomb Company Detail
Table 63. Bausch & Lomb Business Overview
Table 64. Bausch & Lomb Oligonucleotide Therapeutics Drug Product
Table 65. Bausch & Lomb Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 66. Bausch & Lomb Recent Development
Table 67. Alnylam Pharmaceuticals Company Detail
Table 68. Alnylam Pharmaceuticals Business Overview
Table 69. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product
Table 70. Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 71. Alnylam Pharmaceuticals Recent Development
Table 72. Dynavax Technologies Company Detail
Table 73. Dynavax Technologies Business Overview
Table 74. Dynavax Technologies Oligonucleotide Therapeutics Drug Product
Table 75. Dynavax Technologies Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 76. Dynavax Technologies Recent Development
Table 77. Kastle therapeutics Company Detail
Table 78. Kastle therapeutics Business Overview
Table 79. Kastle therapeutics Oligonucleotide Therapeutics Drug Product
Table 80. Kastle therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 81. Kastle therapeutics Recent Development
Table 82. Akcea Therapeutics Company Detail
Table 83. Akcea Therapeutics Business Overview
Table 84. Akcea Therapeutics Oligonucleotide Therapeutics Drug Product
Table 85. Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Drug Business (2018-2024) & (US$ Million)
Table 86. Akcea Therapeutics Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oligonucleotide Therapeutics Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Oligonucleotide Therapeutics Drug Market Share by Type: 2022 VS 2029
Figure 3. Antisense Oligonucleotide Features
Figure 4. Aptamer Features
Figure 5. Other Features
Figure 6. Global Oligonucleotide Therapeutics Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Oligonucleotide Therapeutics Drug Market Share by Application: 2022 VS 2029
Figure 8. Neuromuscular Diseases Case Studies
Figure 9. ATTR Case Studies
Figure 10. Hepatic VOD Case Studies
Figure 11. Other Case Studies
Figure 12. Oligonucleotide Therapeutics Drug Report Years Considered
Figure 13. Global Oligonucleotide Therapeutics Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Oligonucleotide Therapeutics Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oligonucleotide Therapeutics Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Oligonucleotide Therapeutics Drug Market Share by Players in 2022
Figure 17. Global Top Oligonucleotide Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oligonucleotide Therapeutics Drug Revenue in 2022
Figure 19. North America Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Oligonucleotide Therapeutics Drug Market Share by Country (2018-2029)
Figure 21. United States Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oligonucleotide Therapeutics Drug Market Share by Country (2018-2029)
Figure 25. Germany Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Oligonucleotide Therapeutics Drug Market Share by Region (2018-2029)
Figure 33. China Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Oligonucleotide Therapeutics Drug Market Share by Country (2018-2029)
Figure 41. Mexico Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Oligonucleotide Therapeutics Drug Market Share by Country (2018-2029)
Figure 45. Turkey Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Oligonucleotide Therapeutics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Biogen Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 49. Jazz Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 50. Bausch & Lomb Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 52. Dynavax Technologies Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 53. Kastle therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 54. Akcea Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Drug Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries